We use innovative methods to diagnose and stage cancer, track patients’ treatment response and monitor tumors with greater accuracy and precision over time.
The Discovery™ PET/CT 600 scanner combines positron emission tomography (PET) and computed tomography (CT) imaging technology into one machine. The blending of PET and CT images into one singular image reveals information about both the structure and function of cells and tissues in the body. It also provides greater image accuracy and shortens patient treatment times.
Additionally, the scanner offers advanced motion-management capabilities. Motion in a patient’s body as a result of breathing, the beating heart, and other involuntary movement can reduce image quality and make it difficult to detect small tumors.
The motion-free platform of the Discovery PET/CT 600 scanner allows us to accurately detect multiple small lesions in areas of the body subject to movement. This is especially valuable for breast, lung, colon, renal and prostate cancers.
Advantages of the scanner
- Allows us to accurately identify tumor boundaries, allowing for more targeted and concentrated radiation, and saving viable tissue from radiation exposure
- Can detect lesions down to 2.8 mm, which enables us to find cancer and metastases earlier
- Leads the way in image motion management, adding clarity to areas subject to motion, such as the heart and lungs
- Allows us to review images while the scan is being completed
- Reduces treatment planning from 48 hours to 24 hours
- Features software that memorizes and overlays lesions to detect differences over time
In April 2009, CTCA at Southwestern Regional Medical Center in Tulsa, Oklahoma became the third hospital in the world and the first hospital in the nation to offer the Discovery PET/CT 600 scanner.
Learn more about lung cancer diagnostics